Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Seth Rudnick currently holds 12,358 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Seth Rudnick has been a net seller of GTHX stock. They have purchased $177.0K and sold $3.7M worth of shares.
Seth Rudnick's most recent insider trade was on Jun 29, 2021, when they sold 7,969 shares at $0.39 per share.
Seth Rudnick serves as Executive at G1 Therapeutics, Inc. (GTHX). They have executed 45 insider transactions totaling $3.9M over their tenure at the company.
Seth Rudnick holds the position of Executive at G1 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Seth Rudnick has shown a selling trading pattern, with $177.0K in total purchases and $3.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Seth Rudnick was on Sep 4, 2018, when they sold $569.3K worth of GTHX shares. This transaction involved 9,500 shares at $59.93 per share.
Seth Rudnick currently owns 12,358 shares of G1 Therapeutics, Inc. (GTHX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Seth Rudnick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Seth Rudnick has 45 Form 4 filings on record as an insider at G1 Therapeutics, Inc..
Set alerts for Seth Rudnick and 40,000+ other insiders.